PCN61 Healthcare Costs Comparison of Nivolumab Versus Placebo As Adjuvant Treatment of Patients with Melanoma: A Propensity Score Matched Analysis
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.198
https://www.valueinhealthjournal.com/article/S1098-3015(20)32454-2/fulltext
Title :
PCN61 Healthcare Costs Comparison of Nivolumab Versus Placebo As Adjuvant Treatment of Patients with Melanoma: A Propensity Score Matched Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32454-2&doi=10.1016/j.jval.2020.08.198
First page :
Section Title :
Open access? :
No
Section Order :
10150